VEIL.AI selected for Swiss DayOne Health 4.0 accelerator program

VEIL.AI was one of 15 startups selected from among 170 applicants for the Basel-based accelerator program DayOne Health 4.0, a six-month hybrid accelerator program for health tech startups interfacing with Pharma in the Basel area.

DayOne is based in Basel, the epicenter for pioneering health tech ventures in Switzerland. Their mission is to support startups and aid providers, corporations, and payers through external innovation. The DayOne accelerator began in 2018, is powered by global partners, and has catalyzed 87 international healthcare ventures in medtech and digital health through competitive, equity-free initiatives. The theme of this year’s accelerator is “Harnessing AI, data, and digital tools to power clinical development. 

“The quality and diversity of the submissions for this year’s program were incredibly high, and I am excited to kick off the initial phase of the accelerator in September. All the companies in the cohort are bringing something of significant potential value to the healthtech space and I can’t wait to see how their journeys unfold.”

Cécile Tardy, Manager DayOne Health 4.0 Accelerator

VEIL.AI’s inclusion in this prestigious program underscores its pioneering work in the field of next-generation data anonymization. As the healthcare industry increasingly relies on data-driven insights, VEIL.AI’s technology plays a critical role in enabling the safe and effective use of sensitive information. Its solutions create high-quality, individual-level anonymized and synthetic data, allowing for multi-party data collaborations, re-use of legacy data, and the development of AI algorithms while staying compliant with the stringent regulations like the AI Act, GDPR, and EHDS. VEIL.AI’s capabilities align perfectly with DayOne’s topical theme of “Harnessing AI, data, and digital tools to power clinical development”, offering a unique value proposition that stands out within the cohort.

VEIL.AI will now begin Phase 1 of the acceleration program, fostering valuable connections with fellow startups, mentors, experts and accelerator program sponsors. By participating in this accelerator, VEIL.AI aims to further its mission of transforming the way sensitive health data is handled, ensuring that the benefits of data-driven innovation are realized without compromising patient privacy.

Share this
Facebook
Twitter
LinkedIn
Ready to Transform Your Data?

Connect with our experts to discuss your needs.​

Related posts

Dive deeper into VEIL.AI’s latest news,  insightful articles, white papers, and case studies. Learn how our technology is being applied in real-world scenarios and see the results for yourself.

Last month, VEIL.AI took part in two exciting U.S. events: BiotechX USA in Philadelphia (Sept. 17-18) and the Nordic
VEIL.AI was selected as one of the finalists at the Health-X Innovation Forum and will continue developing the VEIL.AI

Privacy legislation such as the General Data Protection Regulation (GDPR), the upcoming European Health Data Space (EHDS) and the

Subscribe to our newsletter